✦ LIBER ✦

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing

✍ Scribed by Ong, Frank S; Das, Kingshuk; Wang, Jay; Vakil, Hana; Kuo, Jane Z; Blackwell, Wendell-Lamar B; Lim, Stephen W; Goodarzi, Mark O; Bernstein, Kenneth E; Rotter, Jerome I; Grody, Wayne W

Book ID: 115495955
Publisher: Expert Reviews
Year: 2012
Tongue: English
Weight: 417 KB
Volume: 12
Category: Article
ISSN: 1473-7159
DOI: 10.1586/erm.12.59

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers in Oncology || Focus on Perso

Biomarkers in Oncology || Focus on Personalized Molecular Based Medicine

✍ Lenz, Heinz-Josef 📂 Article 📅 2012 🏛 Springer New York ⚖ 793 KB

Molecular diagnostics and personalized m

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

✍ Normanno, Nicola; Rachiglio, Anna Maria; Roma, Cristin; Fenizia, Francesca; Espo 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

The Convergence of Conventional Therapeu

The Convergence of Conventional Therapeutic Drug Monitoring and Pharmacogenetic Testing in Personalized Medicine: Focus on Antidepressants

✍ Sjöqvist, F; Eliasson, E 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

Personalized Medicine for Non–Small-Cell

Personalized Medicine for Non–Small-Cell Lung Cancer: Implications of Recent Advances in Tissue Acquisition for Molecular and Histologic Testing

✍ Andre L. Moreira; Raymond H. Thornton 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 336 KB

The potential use of the neurotensin hig

The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers

✍ Sandra Dupouy; Najat Mourra; Van Kien Doan; Anne Gompel; Marco Alifano; Patricia 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 966 KB